Sharing expertise with regional neighbours
Participants undertook IAEA training hosted by Macquarie University and ANSTO on use of radionuclides for soil and water investigations.
Showing 21 - 40 of 99 results
Deuteration Research Facility Chemist. National Deuteration Facility
Rao graduated with BSc(chemistry), B.Pharm, M.Pharm (Pharmaceutical Chemistry) and then PhD in Organic Synthesis from University of Wollongong, NSW, Australia.
Australian Synchrotron to join consortium mapping the human brain
Consortium will map the 86 billion nerve cells, 100 trillion connections and neurotransmitters in the human brain.
Sample Environments Group Leader
Role at ANSTO
Research brings new insights to the complex immune response in the brain
New partnership
Australia and Sri Lanks signs new partnership to fight chronic kidney disease.
PET innovation
Tool developed for producing F-18 radiopharmaceuticals for PET imaging.
Making science accessible to everyone: new initiative for the Deaf community
ANSTO was proud to support the first science-themed AuslanX event for the greater Sydney Deaf community during National Science Week.
Instrument Scientist (The triple-axis spectrometers Sika and Taipan)
Role at ANSTO
ANSTO taking part in international coastal pollution studies
A landmark year and bright future at the Australian Synchrotron
A closer look at the science of detecting flu
Immune system's friendly fire can turn malaria deadly
Australian researchers reveal how the immune system’s ‘friendly fire’ can turn malaria deadly
Meet some of the women from the history of ANSTO who were pioneers in their time
The celebration of the UN’s International Women’s Day 2023 has a theme that highlights the power of innovative IT to combat discrimination and the marginalisation of women globally.
Business case to inform direction of Australian nuclear medicine
Consultant appointed to consider a variety of financial, manufacture and import options.
Tracking oxytocin to understand the biological pathways linked to human cognition and behaviour
Nanoprobe beamline (NANO) - under construction
The BRIGHT Nanoprobe beamline provides a unique facility capable of spectroscopic and full-field imaging. NANO will undertake high-resolution elemental mapping and ptychographic coherent diffraction imaging. Elemental mapping and XANES studies (after DCM upgrade) will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using ptychography.
Funding supports biomedical research
ANSTO part of consortium funded by Federal Government to develop new radioimmunological drugs.
Innovative cancer research
An ANSTO radiochemist has been awarded a scholarship to carry out research at the world-renowned Sloan Kettering Cancer Center in New York.